Search research articles
Contact Us
Filters
Showing results (1-10 of 211) with videos related to
Page
of 22
Sort By:
The Lancet. Oncology
|
June 28, 2015
The place of PD-1 inhibitors in melanoma management
Samantha Bowyer, Paul Lorigan
Expert Review of Anticancer Therapy
|
December 20, 2012
Advances in the management of melanoma: targeted therapy, immunotherapy and future directions
Emma Dean, Paul Lorigan
Drugs
|
April 12, 2005
Improving outcomes in advanced malignant melanoma: update on systemic therapy
Sarah Danson, Paul Lorigan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2024
Combination Immunotherapy for Advanced Melanoma-How to Choose?
Sophia Kreft, Paul Lorigan
Nature Reviews. Clinical Oncology
|
April 26, 2017
Immunotherapy: Does adjuvant ipilimumab have little adverse effect on quality of life?
Paul Lorigan, Adele C Green
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 18, 2012
Efficacy of positron emission tomography staging for small-cell lung cancer: a systematic review and cost analysis in the Australian setting
Corinne Faivre-Finn, Paul Lorigan
BMJ (Clinical Research Ed.)
|
July 6, 2012
Identifying melanomas in primary care: can we do better?
Julia Newton-Bishop, Paul Lorigan
Expert Review of Anticancer Therapy
|
May 12, 2007
Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial
Roberta Ferraldeschi, Nick Thatcher, Paul Lorigan
Melanoma Management
|
September 8, 2018
High-risk cutaneous melanoma follow-up: time for more intensive surveillance?
Michael Davidson, Paul Lorigan, James Larkin
Melanoma Management
|
September 8, 2018
The role for chemotherapy in the modern management of melanoma
Avinash Gupta, Fabio Gomes, Paul Lorigan
Page
of 22
Search research articles
Search
Showing results (1-10 of 211) with videos related to
Sort By:
Page
of 22
The Lancet. Oncology
|
June 28, 2015
The place of PD-1 inhibitors in melanoma management
Samantha Bowyer, Paul Lorigan
Expert Review of Anticancer Therapy
|
December 20, 2012
Advances in the management of melanoma: targeted therapy, immunotherapy and future directions
Emma Dean, Paul Lorigan
Drugs
|
April 12, 2005
Improving outcomes in advanced malignant melanoma: update on systemic therapy
Sarah Danson, Paul Lorigan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2024
Combination Immunotherapy for Advanced Melanoma-How to Choose?
Sophia Kreft, Paul Lorigan
Nature Reviews. Clinical Oncology
|
April 26, 2017
Immunotherapy: Does adjuvant ipilimumab have little adverse effect on quality of life?
Paul Lorigan, Adele C Green
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 18, 2012
Efficacy of positron emission tomography staging for small-cell lung cancer: a systematic review and cost analysis in the Australian setting
Corinne Faivre-Finn, Paul Lorigan
BMJ (Clinical Research Ed.)
|
July 6, 2012
Identifying melanomas in primary care: can we do better?
Julia Newton-Bishop, Paul Lorigan
Expert Review of Anticancer Therapy
|
May 12, 2007
Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial
Roberta Ferraldeschi, Nick Thatcher, Paul Lorigan
Melanoma Management
|
September 8, 2018
High-risk cutaneous melanoma follow-up: time for more intensive surveillance?
Michael Davidson, Paul Lorigan, James Larkin
Melanoma Management
|
September 8, 2018
The role for chemotherapy in the modern management of melanoma
Avinash Gupta, Fabio Gomes, Paul Lorigan
Page
of 22